A novel hotspot of gelsolin instability and aggregation propensity triggers a new mechanism of amyloidosis
Authors:
Michela Bollati,
Luisa Diomede,
Toni Giorgino,
Carmina Natale,
Elisa Fagnani,
Irene Boniardi,
Alberto Barbiroli,
Rebecca Alemani,
Marten Beeg,
Marco Gobbi,
Ana Fakin,
Eloise Mastrangelo,
Mario Milani,
Gianluca Presciuttini,
Edi Gabellieri,
Patrizia Cioni,
Matteo de Rosa
Abstract:
The multidomain protein gelsolin (GSN) is composed of six homologous modules, sequentially named G1 to G6. Single point substitutions in this protein are responsible for AGel amyloidosis, a hereditary disease characterized by progressive corneal lattice dystrophy, cutis laxa, and polyneuropathy. Several different amyloidogenic variants of GSN have been identified over the years, but only the most…
▽ More
The multidomain protein gelsolin (GSN) is composed of six homologous modules, sequentially named G1 to G6. Single point substitutions in this protein are responsible for AGel amyloidosis, a hereditary disease characterized by progressive corneal lattice dystrophy, cutis laxa, and polyneuropathy. Several different amyloidogenic variants of GSN have been identified over the years, but only the most common D187N/Y mutants, in G2, have been thoroughly characterized, and the underlying functional mechanistic link between mutation, altered protein structure, susceptibility to aberrant furin cleavage and aggregative potential resolved. Little is known about the recently identified mutations A551P, E553K and M517R hosted at the interface between G4 and G5, whose aggregation process likely follows an alternative pathway. We demonstrate that these three substitutions impair temperature and pressure stability of GSN but do not increase its susceptibility to furin cleavage, the first event of the canonical aggregation pathway. The variants are also characterized by a higher tendency to aggregate in the unproteolysed forms and show a higher proteotoxicity in a C. elegans-based assay. Structural studies point to a destabilization of the interface between G4 and G5 due to three different structural determinants: beta-strand breaking, steric hindrance and/or charge repulsion, all implying the impairment of interdomain contacts. All available evidence suggests that the rearrangement of the protein global architecture triggers a furin-independent aggregation of the protein, supporting the existence of a non-canonical pathway of gelsolin amyloidosis pathogenesis.
△ Less
Submitted 15 September, 2021;
originally announced September 2021.
Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant
Authors:
Toni Giorgino,
Davide Mattioni,
Amal Hassan,
Mario Milani,
Eloise Mastrangelo,
Alberto Barbiroli,
Adriaan Verhelle,
Jan Gettemans,
Maria Monica Barzago,
Luisa Diomede,
Matteo de Rosa
Abstract:
AGel amyloidosis, formerly known as familial amyloidosis of the Finnish-type, is caused by pathological aggregation of proteolytic fragments of plasma gelsolin. So far, four mutations in the gelsolin gene have been reported as responsible for the disease. Although D187N is the first identified variant and the best characterized, its structure has been hitherto elusive. Exploiting a recently-develo…
▽ More
AGel amyloidosis, formerly known as familial amyloidosis of the Finnish-type, is caused by pathological aggregation of proteolytic fragments of plasma gelsolin. So far, four mutations in the gelsolin gene have been reported as responsible for the disease. Although D187N is the first identified variant and the best characterized, its structure has been hitherto elusive. Exploiting a recently-developed nanobody targeting gelsolin, we were able to stabilize the G2 domain of the D187N protein and obtained, for the first time, its high-resolution crystal structure. In the nanobody-stabilized conformation, the main effect of the D187N substitution is the impairment of the calcium binding capability, leading to a destabilization of the C-terminal tail of G2. However, molecular dynamics simulations show that in the absence of the nanobody, D187N-mutated G2 further misfolds, ultimately exposing its hydrophobic core and the furin cleavage site. The nanobody's protective effect is based on the enhancement of the thermodynamic stability of different G2 mutants (D187N, G167R and N184K). In particular, the nanobody reduces the flexibility of dynamic stretches, and most notably decreases the conformational entropy of the C-terminal tail, otherwise stabilized by the presence of the Ca2+ ion. A Caenorhabditis elegans-based assay was also applied to quantify the proteotoxic potential of the mutants and determine whether nanobody stabilization translates into a biologically relevant effect. Successful protection from G2 toxicity in vivo points to the use of C. elegans as a tool for investigating the mechanisms underlying AGel amyloidosis and rapidly screen new therapeutics.
△ Less
Submitted 18 March, 2019;
originally announced March 2019.
